Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Snail family zinc finger 1 pseudogene 1 (SNAI1P1), also known as SNAI1L, is a processed pseudogene on human chromosome 2q34 that shares sequence similarity with the SNAI1 gene encoding a zinc finger transcriptional repressor[4][6]. Unlike SNAI1, SNAI1P1 does not code for a functional protein but has regulatory roles at the RNA level. Recent research indicates SNAI1P1 may function as a competitive endogenous RNA, decoying microRNA-153, and thus preventing miR-153 from repressing SNAI1 mRNA. This molecular interaction results in elevated SNAI1 protein expression, indirectly promoting EMT and increasing the invasive potential of cancer cells, notably in endometrial cancer[2]. It is not a direct therapeutic target and does not encode a receptor, enzyme, transporter, or conventional drug target, but research suggests it could serve as a prognostic biomarker in oncology[2][6].
Acts as a microRNA decoy (competes for miR-153, thereby regulating SNAI1 translation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Snail family zinc finger 1 pseudogene 1 (SNAI1P1).